Literature DB >> 5676002

A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals.

J B Farmer, G P Levy.   

Abstract

1. A comparison of some cardiovascular effects of propranolol, MJ 1999 and quinidine has been made in rats and dogs.2. After intravenous, subcutaneous or oral administration to rats and dogs, propranolol was found to be 2-4 times more potent than MJ 1999 in blocking the chronotropic and vasodepressor responses to intravenously administered isoprenaline.3. Propranolol and quinidine affected the e.c.g. of rats and dogs in a similar manner.4. At dose-levels causing effective blockade of beta-receptors propranolol and MJ 1999 had no hypotensive effect after short- or long-term administration to conscious hypertensive rats and dogs.5. At very high dose-levels propranolol and quinidine, but not MJ 1999, lowered blood pressure in the hypertensive rat. This effect of propranolol is probably related to one or more of the properties that propranolol and quinidine have in common rather than to a blockade of beta-receptors.6. The possible relevance of these results to the use of propranolol as a hypotensive agent in man is discussed.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5676002      PMCID: PMC1703443          DOI: 10.1111/j.1476-5381.1968.tb07955.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.

Authors:  P M Lish; J H Weikel; K W Dungan
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

2.  What is a beta-blocker?

Authors:  R H Thompson; E Letley
Journal:  Lancet       Date:  1967-11-25       Impact factor: 79.321

3.  Effect of propranolol in mild hypertension.

Authors:  J W Paterson; C T Dollery
Journal:  Lancet       Date:  1966-11-26       Impact factor: 79.321

Review 4.  The development of beta adrenergic blocking drugs: a retrospective and prospective evaluation.

Authors:  N C Moran
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

5.  The peripheral vascular effects of propranolol and related compounds.

Authors:  R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1967-02

6.  Hypotensive action of propranolol.

Authors:  H J Waal
Journal:  Clin Pharmacol Ther       Date:  1966 Sep-Oct       Impact factor: 6.875

7.  Antiarrhythmic effects of beta adrenergic blocking agents.

Authors:  B R Lucchesi; L S Whitsitt; J L Stickney
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

8.  Optical isomers of propranolol.

Authors:  R Howe; R G Shanks
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

9.  Propranolol in hypertension.

Authors:  B N Prichard; P M Gillam
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

10.  Propranolol in hypertension.

Authors:  F A Richards
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

View more
  14 in total

1.  Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.

Authors:  J Zaagsma; L Meems; M Boorsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  Proceedings: Effect of propranolol treatment on the development of DOCA/saline hypertension in rats.

Authors:  M D Day; A S Peters
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

3.  Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).

Authors:  I Persson; J Ulrich
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

4.  Effect of propranolol on the blood pressure of normotensive and pinealectomized hypertensive rats.

Authors:  H Karppanen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Inhibition of the carotid sinus reflex by the chronic administration of propranolol.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

6.  Adaptational responses to prolonged beta-adrenoceptor blockade in adult rabbits.

Authors:  A E Raine; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1980-10       Impact factor: 8.739

7.  The mechanism of the augmentation of the pressor response to angiotensinamide and to adrenaline by beta-adrenoceptor blocking agents in the rat.

Authors:  L Peters-Haefeli; E J Kirchertz; R Bally
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

8.  Cardiovascular and respiratory effects of the beta-adrenoceptive antagonist sotalol: studies in health, angina pectoris and obstructive lung disease.

Authors:  N H Areskog; I Cullhed; I Ringqvist; G Ström
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

9.  A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.

Authors:  J G Papp; E M Williams
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

10.  Role of adrenergic neurone blockade in the hypotensive action of propranolol.

Authors:  S Eliash; M Weinstock
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.